Our work, in this regard, presents an explainable and high-performing machine learning strategy, designed to harness the predictive strength of selected clinical data, CT scan features, and radiomic markers for determining EGFR mutation in NSCLC patients. Here, EGFR is linked to non-small cell lung carcinoma.